- Home
- MTEM vs OGEN Comparison
MTEM vs OGEN Comparison
Compare MTEM & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEM
- OGEN
- Stock Information
- Founded
- MTEM 2001
- OGEN 1996
- Country
- MTEM United States
- OGEN United States
- Employees
- MTEM N/A
- OGEN N/A
- Industry
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- MTEM Health Care
- OGEN Health Care
- Exchange
- MTEM Nasdaq
- OGEN Nasdaq
- Market Cap
- MTEM 9.7M
- OGEN 4.5M
- IPO Year
- MTEM N/A
- OGEN N/A
- Fundamental
- Price
- MTEM $0.71
- OGEN $0.34
- Analyst Decision
- MTEM
- OGEN
- Analyst Count
- MTEM 0
- OGEN 0
- Target Price
- MTEM N/A
- OGEN N/A
- AVG Volume (30 Days)
- MTEM 13.4M
- OGEN 389.1K
- Earning Date
- MTEM 11-11-2024
- OGEN 11-07-2024
- Dividend Yield
- MTEM N/A
- OGEN N/A
- EPS Growth
- MTEM N/A
- OGEN N/A
- EPS
- MTEM N/A
- OGEN N/A
- Revenue
- MTEM $25,470,000.00
- OGEN $7,466.00
- Revenue This Year
- MTEM N/A
- OGEN N/A
- Revenue Next Year
- MTEM N/A
- OGEN N/A
- P/E Ratio
- MTEM N/A
- OGEN N/A
- Revenue Growth
- MTEM N/A
- OGEN N/A
- 52 Week Low
- MTEM $0.30
- OGEN $0.29
- 52 Week High
- MTEM $6.48
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- MTEM 38.68
- OGEN 37.15
- Support Level
- MTEM $0.31
- OGEN $0.29
- Resistance Level
- MTEM $1.34
- OGEN $0.45
- Average True Range (ATR)
- MTEM 0.14
- OGEN 0.04
- MACD
- MTEM -0.05
- OGEN 0.02
- Stochastic Oscillator
- MTEM 34.48
- OGEN 28.88
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.